Selected research
Market Structure
Global Anti-Neprilysin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Anti-Neprilysin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Anti-Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Anti-Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Anti-Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Anti-Neprilysin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Anti-Neprilysin include Novartis International AG, Theravance Biopharma Inc., Pharmaleads SA, Oceanic Pharmachem Pvt. Ltd, Cipla Limited and Bioprojet SCR, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Anti-Neprilysin market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Anti-Neprilysin and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Anti-Neprilysin revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Anti-Neprilysin market size, projected growth trends, production technologies, key applications, and end-use industries.
Anti-Neprilysin Segment by Company
Novartis International AG
Theravance Biopharma Inc.
Pharmaleads SA
Oceanic Pharmachem Pvt. Ltd
Cipla Limited
Bioprojet SCR
Anti-Neprilysin Segment by Type
LHW-090
PL-265
STR-324
TD-0714
Sacubitril
Anti-Neprilysin Segment by Application
Retail Pharmacies
Online Pharmacies
Hospital Pharmacies
Anti-Neprilysin Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Anti-Neprilysin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Anti-Neprilysin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Anti-Neprilysin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Anti-Neprilysin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Anti-Neprilysin industry.
Chapter 3: Detailed analysis of Anti-Neprilysin companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-Neprilysinrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- LHW-090
- PL-265
- STR-324
- TD-0714
- Sacubitril
Applications
- Retail Pharmacies
- Online Pharmacies
- Hospital Pharmacies
Companies covered
- Novartis International AG
- Theravance Biopharma Inc.
- Pharmaleads SA
- Oceanic Pharmachem Pvt. Ltd
- Cipla Limited
- Bioprojet SCR
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Anti-Neprilysin Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 LHW-090
- 1.2.3 PL-265
- 1.2.4 STR-324
- 1.2.5 TD-0714
- 1.2.6 Sacubitril
- 1.3 Market Analysis by Application
- 1.3.1 Global Anti-Neprilysin Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Retail Pharmacies
- 1.3.3 Online Pharmacies
- 1.3.4 Hospital Pharmacies
- 1.4 Global Market Growth Prospects
- 1.5 Global Anti-Neprilysin Growth Trends by Region
- 1.5.1 Global Anti-Neprilysin Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Anti-Neprilysin Market Size by Region (2021-2026)
- 1.5.3 Anti-Neprilysin Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Anti-Neprilysin Market Dynamics
- 2.1 Anti-Neprilysin Industry Trends
- 2.2 Anti-Neprilysin Industry Drivers
- 2.3 Anti-Neprilysin Industry Opportunities and Challenges
- 2.4 Anti-Neprilysin Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Anti-Neprilysin Revenue by Company (2021-2026)
- 3.2 Global Anti-Neprilysin Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Anti-Neprilysin Key Company Head office and Area Served
- 3.4 Global Anti-Neprilysin Company, Product Type & Application
- 3.5 Global Anti-Neprilysin Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Anti-Neprilysin Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Anti-Neprilysin Players Market Share by Revenue in 2025
- 3.6.3 2025 Anti-Neprilysin Tier 1, Tier 2, and Tier 3
4 Anti-Neprilysin Market by Type
- 4.1 Global Anti-Neprilysin Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Anti-Neprilysin Market Size by Type (2021-2032)
- 4.3 Global Anti-Neprilysin Market Size Share by Type (2021-2032)
5 Anti-Neprilysin Market by Application
- 5.1 Global Anti-Neprilysin Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Anti-Neprilysin Market Size by Application (2021-2032)
- 5.3 Global Anti-Neprilysin Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Novartis International AG
- 6.1.1 Novartis International AG Company Information
- 6.1.2 Novartis International AG Business Overview
- 6.1.3 Novartis International AG Anti-Neprilysin Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Novartis International AG Anti-Neprilysin Product Portfolio
- 6.1.5 Novartis International AG Recent Developments
- 6.2 Theravance Biopharma Inc.
- 6.2.1 Theravance Biopharma Inc. Company Information
- 6.2.2 Theravance Biopharma Inc. Business Overview
- 6.2.3 Theravance Biopharma Inc. Anti-Neprilysin Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Theravance Biopharma Inc. Anti-Neprilysin Product Portfolio
- 6.2.5 Theravance Biopharma Inc. Recent Developments
- 6.3 Pharmaleads SA
- 6.3.1 Pharmaleads SA Company Information
- 6.3.2 Pharmaleads SA Business Overview
- 6.3.3 Pharmaleads SA Anti-Neprilysin Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Pharmaleads SA Anti-Neprilysin Product Portfolio
- 6.3.5 Pharmaleads SA Recent Developments
- 6.4 Oceanic Pharmachem Pvt. Ltd
- 6.4.1 Oceanic Pharmachem Pvt. Ltd Company Information
- 6.4.2 Oceanic Pharmachem Pvt. Ltd Business Overview
- 6.4.3 Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Oceanic Pharmachem Pvt. Ltd Anti-Neprilysin Product Portfolio
- 6.4.5 Oceanic Pharmachem Pvt. Ltd Recent Developments
- 6.5 Cipla Limited
- 6.5.1 Cipla Limited Company Information
- 6.5.2 Cipla Limited Business Overview
- 6.5.3 Cipla Limited Anti-Neprilysin Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Cipla Limited Anti-Neprilysin Product Portfolio
- 6.5.5 Cipla Limited Recent Developments
- 6.6 Bioprojet SCR
- 6.6.1 Bioprojet SCR Company Information
- 6.6.2 Bioprojet SCR Business Overview
- 6.6.3 Bioprojet SCR Anti-Neprilysin Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Bioprojet SCR Anti-Neprilysin Product Portfolio
- 6.6.5 Bioprojet SCR Recent Developments
7 North America
- 7.1 North America Anti-Neprilysin Market Size (2021-2032)
- 7.2 North America Anti-Neprilysin Market Size by Type
- 7.2.1 North America Anti-Neprilysin Market Size by Type (2021-2026)
- 7.2.2 North America Anti-Neprilysin Market Size by Type (2027-2032)
- 7.2.3 North America Anti-Neprilysin Market Share by Type (2021-2032)
- 7.3 North America Anti-Neprilysin Market Size by Application
- 7.3.1 North America Anti-Neprilysin Market Size by Application (2021-2026)
- 7.3.2 North America Anti-Neprilysin Market Size by Application (2027-2032)
- 7.3.3 North America Anti-Neprilysin Market Share by Application (2021-2032)
- 7.4 North America Anti-Neprilysin Market Size by Country
- 7.4.1 North America Anti-Neprilysin Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Anti-Neprilysin Market Size by Country (2021-2026)
- 7.4.3 North America Anti-Neprilysin Market Size by Country (2027-2032)
- 7.4.4 North America Anti-Neprilysin Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Anti-Neprilysin Market Size (2021-2032)
- 8.2 Europe Anti-Neprilysin Market Size by Type
- 8.2.1 Europe Anti-Neprilysin Market Size by Type (2021-2026)
- 8.2.2 Europe Anti-Neprilysin Market Size by Type (2027-2032)
- 8.2.3 Europe Anti-Neprilysin Market Share by Type (2021-2032)
- 8.3 Europe Anti-Neprilysin Market Size by Application
- 8.3.1 Europe Anti-Neprilysin Market Size by Application (2021-2026)
- 8.3.2 Europe Anti-Neprilysin Market Size by Application (2027-2032)
- 8.3.3 Europe Anti-Neprilysin Market Share by Application (2021-2032)
- 8.4 Europe Anti-Neprilysin Market Size by Country
- 8.4.1 Europe Anti-Neprilysin Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Anti-Neprilysin Market Size by Country (2021-2026)
- 8.4.3 Europe Anti-Neprilysin Market Size by Country (2027-2032)
- 8.4.4 Europe Anti-Neprilysin Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Anti-Neprilysin Market Size (2021-2032)
- 9.2 China Anti-Neprilysin Market Size by Type
- 9.2.1 China Anti-Neprilysin Market Size by Type (2021-2026)
- 9.2.2 China Anti-Neprilysin Market Size by Type (2027-2032)
- 9.2.3 China Anti-Neprilysin Market Share by Type (2021-2032)
- 9.3 China Anti-Neprilysin Market Size by Application
- 9.3.1 China Anti-Neprilysin Market Size by Application (2021-2026)
- 9.3.2 China Anti-Neprilysin Market Size by Application (2027-2032)
- 9.3.3 China Anti-Neprilysin Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Anti-Neprilysin Market Size (2021-2032)
- 10.2 Asia Anti-Neprilysin Market Size by Type
- 10.2.1 Asia Anti-Neprilysin Market Size by Type (2021-2026)
- 10.2.2 Asia Anti-Neprilysin Market Size by Type (2027-2032)
- 10.2.3 Asia Anti-Neprilysin Market Share by Type (2021-2032)
- 10.3 Asia Anti-Neprilysin Market Size by Application
- 10.3.1 Asia Anti-Neprilysin Market Size by Application (2021-2026)
- 10.3.2 Asia Anti-Neprilysin Market Size by Application (2027-2032)
- 10.3.3 Asia Anti-Neprilysin Market Share by Application (2021-2032)
- 10.4 Asia Anti-Neprilysin Market Size by Country
- 10.4.1 Asia Anti-Neprilysin Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Anti-Neprilysin Market Size by Country (2021-2026)
- 10.4.3 Asia Anti-Neprilysin Market Size by Country (2027-2032)
- 10.4.4 Asia Anti-Neprilysin Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Anti-Neprilysin Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Anti-Neprilysin Market Size by Type
- 11.2.1 South America, Middle East & Africa Anti-Neprilysin Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Anti-Neprilysin Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Anti-Neprilysin Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Anti-Neprilysin Market Size by Application
- 11.3.1 South America, Middle East & Africa Anti-Neprilysin Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Anti-Neprilysin Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Anti-Neprilysin Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Anti-Neprilysin Market Size by Country
- 11.4.1 South America, Middle East & Africa Anti-Neprilysin Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Anti-Neprilysin Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Anti-Neprilysin Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Anti-Neprilysin Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst